Research Library
Regulatory and Responsible Research·Regulatory Science·5 min read

Why Compounded Drugs Are Not FDA-Approved Drugs

Compounding can serve legitimate patient needs under defined legal conditions, but compounded products do not undergo FDA premarket approval.

By
Jacob Leisher, Researcher, Cendrix
Reviewed by
Jacob Doyon, Researcher, Cendrix
Published
May 1, 2026
Last reviewed
June 26, 2026

Approval and compounding are different regulatory pathways. Conflating them obscures what has and has not been reviewed.

FDA approval evaluates a specific product

An approved drug is reviewed for a defined formulation, manufacturing process, controls, labeling, and intended use. The review considers evidence of safety and effectiveness and whether the product can be manufactured consistently under applicable requirements.

Compounding operates through statutory exemptions

Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act create pathways under which qualifying compounded drugs may be exempt from certain approval, labeling, and manufacturing provisions. The conditions differ between traditional pharmacies and outsourcing facilities.

Compounded drugs are not preapproved

FDA does not verify the safety, effectiveness, or quality of each compounded product before it reaches a patient. State boards of pharmacy and FDA share oversight in different ways depending on the facility and activity.

'Generic' is not the correct shortcut

An FDA-approved generic must demonstrate required sameness and bioequivalence to a reference product and be manufactured under an approved application. A compounded product is not an approved generic merely because it contains an ingredient with the same name.

Quality is product-specific

Source material, formulation, concentration, excipients, sterility controls, container closure, stability, and handling can all differ. Evidence associated with an approved product does not automatically establish the quality or clinical performance of a compounded version.

Communication should be precise

Businesses should clearly identify whether a product is FDA approved, compounded, investigational, or supplied for research. Ambiguous phrases such as pharmaceutical grade or FDA registered can create a misleading impression if they imply approval.

This article is provided for scientific and educational purposes. It does not describe or recommend human or veterinary use. Research findings may be limited by study design, model selection, material identity, sample size, or lack of independent replication.

Cendrix analysis

molecule-level science is separate from product-level regulatory status. An ingredient may be well studied while a particular preparation remains unapproved and unevaluated.

Selected primary references

  1. [1]FDA: Compounding and FDA Questions and Answers
  2. [2]FDA: FD&C Act provisions that apply to human drug compounding
  3. [3]FDA drug approval database

Editorial note. Written by Jacob Leisher and scientifically reviewed by Jacob Doyon. See our editorial standards, citation policy, and corrections policy.